Cited by 83Aquaculture disease management and microbiotaAmphibian and Reptile BiologyGut microbiota and health

Stability of Microbiota Facilitated by Host Immune Regulation: Informing Probiotic Strategies to Manage Amphibian Disease

Open access
Küng, Denise, Bigler, Laurent, Davis, Leyla R., Gratwicke, Brian, Griffith, Edgardo, Woodhams, Douglas C.·2014·PLoS ONE

Abstract

Microbial communities can augment host immune responses and probiotic therapies are under development to prevent or treat diseases of humans, crops, livestock, and wildlife including an emerging fungal disease of amphibians, chytridiomycosis. However, little is known about the stability of host-associated microbiota, or how the microbiota is structured by innate immune factors including antimicrobial peptides (AMPs) abundant in the skin secretions of many amphibians. Thus, conservation medicine including therapies targeting the skin will benefit from investigations of amphibian microbial ecology that provide a model for vertebrate host-symbiont interactions on mucosal surfaces. Here, we tested whether the cutaneous microbiota of Panamanian rocket frogs, Colostethus panamansis, was resistant to colonization or altered by treatment. Under semi-natural outdoor mesocosm conditions in Panama, we exposed frogs to one of three treatments including: (1) probiotic - the potentially beneficial bacterium Lysinibacillus fusiformis, (2) transplant - skin washes from the chytridiomycosis-resistant glass frog Espadarana prosoblepon, and (3) control - sterile water. Microbial assemblages were analyzed by a culture-independent T-RFLP analysis. We found that skin microbiota of C. panamansis was resistant to colonization and did not differ among treatments, but shifted through time in the mesocosms. We describe regulation of host AMPs that may function to maintain microbial community stability. Colonization resistance was metabolically costly and microbe-treated frogs lost 7-12% of body mass. The discovery of strong colonization resistance of skin microbiota suggests a well-regulated, rather than dynamic, host-symbiont relationship, and suggests that probiotic therapies aiming to enhance host immunity may require an approach that circumvents host mechanisms maintaining equilibrium in microbial communities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0087101

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Authors
Küng, D., Bigler, L., Davis, L. R., Gratwicke, B., Griffith, E., & Woodhams, D. C.
Affiliations
  • University of Zurich (CH)
  • Smithsonian Institution (US)
  • Smithsonian Tropical Research Institute (PA)
Corresponding author
Woodhams, Douglas C.
Venue
PLoS ONE
Published
2014-01-29
Volume
9
Issue
1
Pages
e87101
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2001449554
Cited by
83
References
3
Citations by year
2026: 2 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 6 · 2021: 6 · 2020: 6 · 2019: 9 · 2018: 8 · 2017: 9 · 2016: 10 · 2015: 6 · 2014: 6
FWCI
4.72
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, public-domain)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, public-domain)
Funders
  • National Science Foundation
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (125099)
  • Akademie der Naturwissenschaften
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Aquaculture disease management and microbiota
  • Physical Sciences › Environmental Science › Global and Planetary Change › Amphibian and Reptile Biology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
amphibian skin microbiota, chytridiomycosis, probiotics, Lysinibacillus fusiformis, antimicrobial peptides, colonization resistance, microbial community stability, host-symbiont interactions, Espadarana prosoblepon, conservation medicine, amphibian disease, mesocosm experiment
MeSH terms
Animals, Anura, Bacillus, Dermatomycoses, Chytridiomycota, Skin, Weight Loss, Probiotics, Antimicrobial Cationic Peptides, Amphibian Proteins, Host-Pathogen Interactions, Disease Resistance, Microbiota

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review